UK Scientists Develop A New COVID-19 Treatment

A trial of a new treatment of Coronavirus has started at the Hull Royal Infirmary in the UK.

It involves inhaling a protein known as ‘interferon beta’ which the body generates after getting infected with a viral infection.


Inspectors Cause Irregularities Worth Millions in Faisalabad’s Property Tax

According to details, the new COVID-19 treatment has been developed at the Southampton University Hospital and is being produced by the Southampton-based biotech company, Synairgen.

The researchers claim that the new treatment stimulates the immune system to fight the Coronavirus and reduces the chances of developing a serious infection by 80%.

The new treatment costs around £2,000.

How does it work?

Interferon beta warns the body to expect a viral attack as it is the body’s first line of defense against pathogens.


Multiple Auto Part Importers Evaded Taxes of Rs. 300 Million Over Spark Plugs

After entering the body, the Coronavirus immediately stops its production in a bid to infect the immune system. The new treatment delivers interferon beta directly to the lungs through a nebulizer in the form of an aerosol.

Resultantly, the dose of protein will generate a strong immune anti-viral response after getting infected with Coronavirus, even in individuals with weaker immune systems.

Patients with asthma and other chronic lung conditions can comfortably tolerate the treatment as well.